Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -53.38% · OPTIONAL
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTNeuraxis, INC's latest supported as-filed period reports revenue of $1.9M; gross margin moved 227 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -53.38% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 115.72% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 14.38% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 85.87% · CORE
Level · gp.fundamentals.operating_margin
Raw value -110.16% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 14.22% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +39.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross margin changed +227 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed +121.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
NRXS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-039247SEC ↗4Aug 17, 2026Period Aug 13, 20260001493152-26-038831SEC ↗4Aug 17, 2026Period Aug 13, 20260001493152-26-038829SEC ↗4Aug 17, 2026Period Aug 13, 20260001493152-26-038827SEC ↗4Aug 17, 2026Period Aug 13, 20260001493152-26-038824SEC ↗4Aug 17, 2026Period Aug 13, 20260001493152-26-038821SEC ↗4Aug 17, 2026Period Aug 13, 20260001493152-26-038819SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 13, 2026Filed Aug 17, 2026 | Watkins Bradley MitchellDirector | Grant Or AwardDirect | 26,073 | $6 | $163,738 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 0.00% · OPTIONAL
Inventory changed +111.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -23.4% from the comparable as-filed period.
Operating income changed -23.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +8197 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-12-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-038817